Understanding hepcidin for iron management in pregnancy

Area of Science:

• Obstetrics and Gynecology
• Hematology
• Nutritional Science

Background:

• Iron deficiency anaemia (IDA) affects up to 30% of pregnant women in the UK, leading to adverse maternal and infant outcomes.
• Current diagnostic and therapeutic strategies for IDA in pregnancy are limited, necessitating improved approaches.
• Hepcidin, a key regulator of iron metabolism, shows potential for personalized iron supplementation.

Purpose of the Study:

• To review and synthesize existing evidence on the role of hepcidin in guiding iron therapy for pregnant women with IDA.
• To explore the utility of hepcidin in tailoring iron supplementation based on individual needs and responsiveness.
• To identify gaps in current research and suggest future directions for managing IDA in pregnancy.

Main Methods:

• A comprehensive literature review was conducted.
• Existing evidence on hepcidin's role in iron metabolism during pregnancy was synthesized.
• Studies investigating hepcidin-based approaches for IDA management were critically evaluated.

Main Results:

• Hepcidin's role in iron regulation is complex and its application in personalized iron therapy for pregnant women with IDA is still under investigation.
• Current research on hepcidin-based interventions yields mixed findings, highlighting the need for further clarification.
• Understanding hepcidin levels could potentially optimize iron supplementation strategies.

Conclusions:

• Hepcidin holds promise for personalized iron supplementation in pregnant women with IDA.
• Further research is crucial to elucidate hepcidin's precise role and validate its clinical utility in managing IDA during pregnancy.
• Improved management strategies are needed to address the significant health challenge of IDA in pregnancy.